Why Generic EpiPen Is Not The Answer – Until FDA Says It Is

There is no question that the concerns over Mylan’s price increases for EpiPen would deflate as rapidly as the price once an interchangeable generic is approved by FDA, but putting pressure on FDA to get a generic to market may be counterproductive.

EpiPen 2-pak

More from United States

More from North America